<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2448-8909</journal-id>
<journal-title><![CDATA[Medicina crítica (Colegio Mexicano de Medicina Crítica)]]></journal-title>
<abbrev-journal-title><![CDATA[Med. crít. (Col. Mex. Med. Crít.)]]></abbrev-journal-title>
<issn>2448-8909</issn>
<publisher>
<publisher-name><![CDATA[Colegio Mexicano de Medicina Crítica A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2448-89092024000600419</article-id>
<article-id pub-id-type="doi">10.35366/119227</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Frecuencia de los fenotipos de choque cardiogénico, correlación con clasificación SCAI y mortalidad en terapia intensiva]]></article-title>
<article-title xml:lang="en"><![CDATA[Cardiogenic shock frequency, correlation with SCAI classification and mortality in intensive care]]></article-title>
<article-title xml:lang="pt"><![CDATA[Frequência de fenótipos de choque cardiogênico, correlação com a classificação SCAI e mortalidade na unidade de terapia intensiva]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Queb Pech]]></surname>
<given-names><![CDATA[Nadia Melisa]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rocha Botello]]></surname>
<given-names><![CDATA[Estefanía]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Gaytán García]]></surname>
<given-names><![CDATA[Cristhian Josué]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Aguirre Sánchez]]></surname>
<given-names><![CDATA[Janet Silvia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Martínez Díaz]]></surname>
<given-names><![CDATA[Braulia Aurelia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Centro Médico ABC  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>México</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2024</year>
</pub-date>
<volume>38</volume>
<numero>6</numero>
<fpage>419</fpage>
<lpage>426</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2448-89092024000600419&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2448-89092024000600419&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2448-89092024000600419&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Introducción:  El choque cardiogénico (CC) es un síndrome que genera estancias prolongadas en unidades de cuidados intensivos, aumenta la morbilidad a largo plazo, con un significante costo económico e impacto en la calidad de vida relacionada con la salud de los sobrevivientes. El Grupo de Trabajo en Choque Cardiogénico (CSWG) propuso una subclasificación de CC en tres fenotipos, asociados sinérgicamente con la clasificación de la Sociedad de Angiografía e Intervenciones Coronarias (SCAI) para una mayor correlación pronóstica.  Objetivo:  Determinar la incidencia de cada fenotipo de CC y su asociación con la mortalidad en un entorno de cuidados intensivos en México.  Material y métodos:  Cohorte histórica que incluyó pacientes ingresados en la unidadx de cuidados intensivos con diagnóstico de CC de acuerdo con los criterios de CSWG y SCAI. Fueron incluidos fenotipos en estadios C, D y E.  Resultados:  De enero de 2021 a enero de 2023 se estudiaron 65 pacientes ingresados en la unidad de cuidados intensivos con diagnóstico de CC. De estos, 55% (n = 36) eran hombres y 45% (n = 29) mujeres, con edad promedio de 65.7 ± 15.2 años. La distribución por fenotipos fue: 49% correspondientes al fenotipo I, 40% al fenotipo II y 11% al fenotipo III. Murieron 46% con fenotipo I, 27% con fenotipo II y 27% con fenotipo III. De acuerdo con la estadificación del SCAI, 2% de los pacientes se identificaron en la etapa C, 72% en la etapa D y 26% en la etapa E. La etiología principal fue la insuficiencia cardiaca (IC) descompensada y el tratamiento farmacológico predominó; sólo 7.6% recibiendo apoyo mecánico.  Conclusiones:  Se logró determinar la incidencia de cada fenotipo de CC y su asociación con la mortalidad. La principal causa de mortalidad por fenotipo observada en nuestra población difiere de estudios anteriores. Este estudio es el primero en examinar la clasificación por fenotipos en nuestro país y establecer su asociación con la clasificación SCAI y mortalidad, destacando la necesidad de estudios prospectivos con cohortes más grandes.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract:  Introduction:  Cardiogenic shock (CS) is a syndrome that results in prolonged stays in intensive care units, increases long-term morbidity, and comes with significant economic costs and impacts on survivors&#8217; health-related quality of life. The Cardiogenic Shock Working Group (CSWG) proposed a sub-classification of CS into three phenotypes, synergistically associated with the Society for Cardiovascular Angiography and Interventions (SCAI) classification to improve prognostic correlation.  Objective:  Our research aims to explore the incidence of each CS phenotype and its association with mortality in an intensive care setting in Mexico.  Material and methods:  This is a historical cohort study that included patients admitted to the intensive care unit with a diagnosis of CS according to CSWG and SCAI criteria. The study included phenotypes in stages C, D, and E.  Results:  From January 2021 to January 2023, 65 patients admitted to the intensive care unit with a diagnosis of CS were studied. Of these, 55% (n = 36) were men, and 45% (n = 29) were women, with an average age of 65.7 ± 15.2 years. The distribution by phenotypes was 49% corresponding to phenotype I, 40% to phenotype II, and 11% to phenotype III. Mortality rates were 46% for phenotype I, 27% for phenotype II, and 27% for phenotype III. According to SCAI staging, 2% of the patients were identified in stage C, 72% in stage D, and 26% in stage E. The primary etiology was decompensated heart failure, and pharmacological treatment predominated, with only 7.6% receiving mechanical support.  Conclusion:  It was possible to determine the incidence of each CS phenotype and its association with mortality; the main cause of mortality by phenotype observed in our population differs from previous studies, potentially due to the predominant etiology in our population. This study is the first to examine phenotype classification in our country and establish its association with mortality and SCAI classification, highlighting the need for prospective studies with larger cohorts.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo:  Introdução:  O choque cardiogênico (CC) é uma síndrome que resulta em internações prolongadas em unidades de terapia intensiva, aumenta a morbidade em longo prazo, com custo econômico significativo e impacto na qualidade de vida relacionada à saúde dos sobreviventes. O Cardiogenic Shock Working Group (CSWG) propôs uma subclassificação do CC em três fenótipos, sinergicamente associados à classificação da Society for Coronary Angiography and Interventions (SCAI) para uma melhor correlação prognóstica.  Objetivo:  Determinar a incidência de cada fenótipo de CC e sua associação com a mortalidade em um ambiente de terapia intensiva no México.  Material e métodos:  Coorte histórica incluindo pacientes admitidos na unidade de terapia intensiva com diagnóstico de CC de acordo com os critérios CSWG e SCAI, incluindo fenótipos nos estágios C, D e E.  Resultados:  De janeiro de 2021 a janeiro de 2023, foram estudados 65 pacientes admitidos na unidade de terapia intensiva com diagnóstico de CC. Desses, 55% (n = 36) eram do sexo masculino e 45% (n = 29) do sexo feminino, com idade média de 65.7 ± 15.2 anos. A distribuição por fenótipos foi de 49% correspondente ao fenótipo I, 40% ao fenótipo II e 11% ao fenótipo III. Quarenta e seis por cento morreram com o fenótipo I, 27% com o fenótipo II e 27% com o fenótipo III. De acordo com o estadiamento da SCAI, 2% dos pacientes foram identificados como estágio C, 72% como estágio D e 26% como estágio E. A principal etiologia foi a IC descompensada e o tratamento farmacológico predominou, com apenas 7.6% recebendo suporte mecânico.  Conclusões:  Conseguimos determinar a incidência de cada fenótipo de CC e sua associação com a mortalidade; a principal causa de mortalidade por fenótipo observada em nossa população difere de estudos anteriores. Este estudo é o primeiro a examinar a classificação do fenótipo em nosso país e estabelecer sua associação com a classificação SCAI e a mortalidade, destacando a necessidade de estudos prospectivos com coortes maiores.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[choque cardiogénico]]></kwd>
<kwd lng="es"><![CDATA[fenotipo]]></kwd>
<kwd lng="es"><![CDATA[SCAI]]></kwd>
<kwd lng="en"><![CDATA[cardiogenic shock]]></kwd>
<kwd lng="en"><![CDATA[phenotype]]></kwd>
<kwd lng="en"><![CDATA[SCAI]]></kwd>
<kwd lng="pt"><![CDATA[choque cardiogênico]]></kwd>
<kwd lng="pt"><![CDATA[fenótipo]]></kwd>
<kwd lng="pt"><![CDATA[SCAI]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chien]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[HY]]></given-names>
</name>
<name>
<surname><![CDATA[Lin]]></surname>
<given-names><![CDATA[CF]]></given-names>
</name>
<name>
<surname><![CDATA[Huang]]></surname>
<given-names><![CDATA[CY]]></given-names>
</name>
<name>
<surname><![CDATA[Chien]]></surname>
<given-names><![CDATA[LN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comparison of the prognosis among in-hospital survivors of cardiogenic shock based on etiology: AMI and Non-AMI]]></article-title>
<source><![CDATA[Ann Intensiv Care]]></source>
<year>2024</year>
<volume>14</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>74</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shirakabe]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Matsushita]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Shibata]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Shighihara]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Nishigoori]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Sawatani]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Organ dysfunction, injury, and failure in cardiogenic shock]]></article-title>
<source><![CDATA[J Intensiv Care]]></source>
<year>2023</year>
<volume>11</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>26</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Camacho]]></surname>
<given-names><![CDATA[CEG]]></given-names>
</name>
<name>
<surname><![CDATA[Sigarroa]]></surname>
<given-names><![CDATA[ER]]></given-names>
</name>
<name>
<surname><![CDATA[Cherit]]></surname>
<given-names><![CDATA[GD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Choque cardiogénico: de la definición al abordaje]]></article-title>
<source><![CDATA[Med Crtt]]></source>
<year>2019</year>
<volume>33</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>251-8</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sarma]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Jentzer]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Soussi]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cardiogenic shock: a major challenge for the clinical trialist]]></article-title>
<source><![CDATA[Curr Opin Crit Care]]></source>
<year>2023</year>
<volume>29</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>371-80</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kapur]]></surname>
<given-names><![CDATA[NK]]></given-names>
</name>
<name>
<surname><![CDATA[Kanwar]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Sinha]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
<name>
<surname><![CDATA[Thayer]]></surname>
<given-names><![CDATA[KL]]></given-names>
</name>
<name>
<surname><![CDATA[Garan]]></surname>
<given-names><![CDATA[AR]]></given-names>
</name>
<name>
<surname><![CDATA[Hernandez-Montfort]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Criteria for defining stages of cardiogenic shock severity]]></article-title>
<source><![CDATA[J Am Coll Cardiol]]></source>
<year>2022</year>
<volume>80</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>185-98</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tehrani]]></surname>
<given-names><![CDATA[BN]]></given-names>
</name>
<name>
<surname><![CDATA[Truesdell]]></surname>
<given-names><![CDATA[AG]]></given-names>
</name>
<name>
<surname><![CDATA[Psotka]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Rosner]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Singh]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Sinha]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A standardized and comprehensive approach to the management of cardiogenic shock]]></article-title>
<source><![CDATA[Jacc Hear Fail]]></source>
<year>2020</year>
<volume>8</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>879-91</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zweck]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Thayer]]></surname>
<given-names><![CDATA[KL]]></given-names>
</name>
<name>
<surname><![CDATA[Helgestad]]></surname>
<given-names><![CDATA[OKL]]></given-names>
</name>
<name>
<surname><![CDATA[Kanwar]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ayouty]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Garan]]></surname>
<given-names><![CDATA[AR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Phenotyping cardiogenic shock]]></article-title>
<source><![CDATA[J Am Hear Assoc: Cardiovasc Cerebrovasc Dis]]></source>
<year>2020</year>
<volume>10</volume>
<numero>14</numero>
<issue>14</issue>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jones]]></surname>
<given-names><![CDATA[TL]]></given-names>
</name>
<name>
<surname><![CDATA[Nakamura]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[McCabe]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cardiogenic shock: evolving definitions and future directions in management]]></article-title>
<source><![CDATA[Open Hear]]></source>
<year>2019</year>
<volume>6</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zweck]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Kanwar]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Sinha]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
<name>
<surname><![CDATA[Garan]]></surname>
<given-names><![CDATA[AR]]></given-names>
</name>
<name>
<surname><![CDATA[Hernandez-Montfort]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical course of patients in cardiogenic shock stratified by phenotype]]></article-title>
<source><![CDATA[JACC: Hear Fail]]></source>
<year>2023</year>
<volume>11</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1304-15</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Geller]]></surname>
<given-names><![CDATA[BJ]]></given-names>
</name>
<name>
<surname><![CDATA[Sinha]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
<name>
<surname><![CDATA[Kapur]]></surname>
<given-names><![CDATA[NK]]></given-names>
</name>
<name>
<surname><![CDATA[Bakitas]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Balsam]]></surname>
<given-names><![CDATA[LB]]></given-names>
</name>
<name>
<surname><![CDATA[Chikwe]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Escalating and de-escalating temporary mechanical circulatory support in cardiogenic shock: a scientific statement from the American Heart Association]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2022</year>
<volume>146</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>e50-68</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lim]]></surname>
<given-names><![CDATA[HS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Phenotyping and hemodynamic assessment in cardiogenic shock: from physiology to clinical application]]></article-title>
<source><![CDATA[Cardiol Ther]]></source>
<year>2022</year>
<volume>11</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>509-22</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
